Efficacy of doxorubicin and lipiodol therapy by trans-arterial chemoembolization in hepatocellular carcinoma Egyptian patients and relation to genetic polymorphisms-Reference-Cited by-同舟云学术

Efficacy of doxorubicin and lipiodol therapy by trans-arterial chemoembolization in hepatocellular carcinoma Egyptian patients and relation to genetic polymorphisms

Published:2024-08-21 Issue: Volume: Page:1-12
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Werida Rehab H.¹^ORCID,Abd El Baset Omnia A.²^ORCID,Askar Safaa³^ORCID,El-Mohamdy Marwa⁴,Omran Gamal A.⁵,Hagag Radwa Samir²^ORCID

Affiliation:

1. Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt

2. Department of Clinical pharmacy and pharmacy practice, Faculty of pharmacy, Egyptian Russian University, Cairo, Egypt

3. Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

4. Clinical Pathology Department, Faculty of Medicine, Ain Shams university, Cairo, Egypt

5. Department of Biochemistry, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2024.2391364

Reference35 articles.

1. Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making

2. Malignant tumours of the liver

3. Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma

4. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma

5. Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis